BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 879324)

  • 1. Renal extraction of glucagon in rats with normal and reduced renal function.
    Bastl C; Finkelstein FO; Sherwin R; Hendler R; Felig P; Hayslett JP
    Am J Physiol; 1977 Jul; 233(1):F67-71. PubMed ID: 879324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon metabolism in the rat.
    Emmanouel DS; Jaspan JB; Rubenstein AH; Huen AH; Fink E; Katz AI
    J Clin Invest; 1978 Jul; 62(1):6-13. PubMed ID: 659638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of polypeptide hormones by the normal kidney and in uremia.
    Katz AI; Emmanouel DS
    Nephron; 1978; 22(1-3):69-80. PubMed ID: 370635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism.
    Polonsky K; Jaspan J; Emmanouel D; Holmes K; Moossa AR
    Acta Endocrinol (Copenh); 1983 Mar; 102(3):420-7. PubMed ID: 6338678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog.
    Hagopian W; Lever EG; Cohen D; Emmanouel D; Polonsky KS; Pugh W; Moossa A; Jaspan JB
    Am J Physiol; 1983 Aug; 245(2):E171-7. PubMed ID: 6881330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of polypeptide hormones by the kidney.
    Ardaillou R; Paillard F
    Adv Nephrol Necker Hosp; 1980; 9():247-69. PubMed ID: 6773315
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
    Blonde L; Wehmann RE; Steiner AL
    J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal catabolism of 125I-glicentin.
    López-Novoa JM; Santos JC; Villamediana LM; Garrote FJ; Thim L; Moody AJ; Valverde I
    Am J Physiol; 1986 May; 250(5 Pt 1):E545-50. PubMed ID: 3706521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of four methods for measuring glomerular filtration rate by inulin clearance in healthy individuals and patients with renal failure].
    Hernández Ocampo J; Torres Rosales A; Rodríguez Castellanos F
    Nefrologia; 2010; 30(3):324-30. PubMed ID: 20414326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and characterization of hyperglucagonemia in the uremic rat.
    Emmanouel DS; Jaspan JB; Kuku SF; Rubenstein AH; Katz AI; Huen AH
    J Clin Invest; 1976 Nov; 58(5):1266-72. PubMed ID: 993345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal catabolism of truncated glucagon-like peptide 1.
    Ruiz-Grande C; Alarcón C; Alcántara A; Castilla C; López Novoa JM; Villanueva-Peñacarrillo ML; Valverde I
    Horm Metab Res; 1993 Dec; 25(12):612-6. PubMed ID: 8119664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independance of glucagon and insulin handling by the isolated perfused dog kidney.
    Lefebvre PJ; Luyckx AS; Nizet AH
    Diabetologia; 1976 Aug; 12(4):359-65. PubMed ID: 1085708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of proinsulin, insulin, and C-peptide in the rat.
    Katz AI; Rubenstein AH
    J Clin Invest; 1973 May; 52(5):1113-21. PubMed ID: 4700486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive renal insufficiency induces increasing protection against ischemic acute renal failure.
    Zager RA; Baltes LA
    J Lab Clin Med; 1984 Apr; 103(4):511-23. PubMed ID: 6699471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic glucagon metabolism. Correlation of hormone processing by isolated canine hepatocytes with glucagon metabolism in man and in the dog.
    Hagopian WA; Tager HS
    J Clin Invest; 1987 Feb; 79(2):409-17. PubMed ID: 2879853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of hyperinsulinemia and hyperglucagonemia after liver transplantation.
    Sika M; Blair KT; Jabbour K; Williams PE; Donovan KL; Drougas JG; Becker YT; Bradley AL; Van Buren DH; Flakoll PJ; Chapman WC; Wright JK; Pinson CW
    J Surg Res; 1997 Jul; 70(2):144-50. PubMed ID: 9245563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of IGF-I on renal function in patients with chronic renal failure.
    O'Shea MH; Miller SB; Hammerman MR
    Am J Physiol; 1993 May; 264(5 Pt 2):F917-22. PubMed ID: 8498545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal handling of endogenous glucagon in the dog: comparison with insulin.
    Lefebvre PJ; Luyckx AS; Nizet H
    Metabolism; 1974 Aug; 23(8):753-61. PubMed ID: 4605042
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.